FUNI (Hypha Labs) Short-Term Debt : $1.08 Mil (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hypha Labs Short-Term Debt?

Hypha Labs's Short-Term Debt for the quarter that ended in Jun. 2024 was $1.08 Mil.

Hypha Labs's quarterly Short-Term Debt declined from Dec. 2023 ($2.35 Mil) to Mar. 2024 ($1.08 Mil) but then stayed the same from Mar. 2024 ($1.08 Mil) to Jun. 2024 ($1.08 Mil).

Hypha Labs's annual Short-Term Debt increased from Sep. 2021 ($1.31 Mil) to Sep. 2022 ($1.86 Mil) and increased from Sep. 2022 ($1.86 Mil) to Sep. 2023 ($2.29 Mil).

Hypha Labs Short-Term Debt Historical Data

The historical data trend for Hypha Labs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypha Labs Short-Term Debt Chart

Hypha Labs Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Short-Term Debt

Get a 7-Day Free Trial

0.20

0.10

1.31

1.86

2.29

Hypha Labs Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Short-Term Debt	Get a 7-Day Free Trial															2.36	2.29	2.35	1.08	1.08

Hypha Labs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Hypha Labs Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Hypha Labs's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypha Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hypha Labs Inc (OTCPK:FUNI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118

Website

https://www.hyphalabs.com

Hypha Labs Inc has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes 6-8 weeks to fully grow mushrooms, and using Hyphalabs technology the production of the active ingredient is only 7-10 days. This natural product solves the dosing issue created by having to use whole mushrooms currently. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits.

Executives

A Stone Douglass	director	10200 WILLOW CREEK ROAD, SAN DIEGO CA 92131
Edmond Defrank	director	19360 RINALDI STREET, #448, NORTHRIDGE CA 91326
Kyle Remenda	officer: Chief Executive Officer	111-2532 SHORELINE DRIVE, LAKE COUNTRY A1 V4V2R6
Dennis Hartmann	director	1600 CAMDEN AVENUE, NO. 103, LOS ANGELES CA 90025
Bruce I Raben	director	430 VICTORIA TERRACE, RIDGEFIELD NJ 7657
Cindy Sue Orser	director	4507 APPLE WAY, BOULDER CO 80301
Alfredo Axtmayer	director	287 PAYNE DRIVE, CHESHIRE CT 06410
Joseph J Bianco	director	611 BROADWAY,, SUITE 307, NEW YORK NY 10012
Todd A Peterson	officer: Chief Financial Officer	3608 MALLARDWOOD DRIVE, LAS VEGAS NV 89129
Joe D Tanner	director	28720 ROADSIDE DRIVE, SUITE 128, AGOURA HILLS CA 91301
Raw Alternative, Llc	10 percent owner	16030 VENTURA BLVD. SUITE 380, ENCINO CA 91436
Todd Denkin	director, officer: President	C/O PHOTOTRON, INC., 20259 VENTURA BLVD., WOODLAND HILLS CA 91364
Barbee Denny Barbee	10 percent owner	3105 EAST CENTRAL, #114, WICHITA KS 67214
Eric Stoppenhagen	director, 10 percent owner, officer: CFO	8908 SPLITARROW DRIVE, AUSTIN TX 78717